277 related articles for article (PubMed ID: 21269443)
1. Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder.
Tadić A; Wagner S; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Lieb K
BMC Psychiatry; 2011 Jan; 11():16. PubMed ID: 21269443
[TBL] [Abstract][Full Text] [Related]
2. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
[TBL] [Abstract][Full Text] [Related]
3. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.
Lam RW; Milev R; Rotzinger S; Andreazza AC; Blier P; Brenner C; Daskalakis ZJ; Dharsee M; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Geraci J; Giacobbe P; Feilotter HE; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; Liotti M; MacQueen GM; McAndrews MP; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Salomons TV; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Kennedy SH;
BMC Psychiatry; 2016 Apr; 16():105. PubMed ID: 27084692
[TBL] [Abstract][Full Text] [Related]
4. The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study.
Tadić A; Wagner S; Schlicht KF; Peetz D; Borysenko L; Dreimüller N; Hiemke C; Lieb K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):415-20. PubMed ID: 20732374
[TBL] [Abstract][Full Text] [Related]
5. The establishment of the objective diagnostic markers and personalized medical intervention in patients with major depressive disorder: rationale and protocol.
Lv X; Si T; Wang G; Wang H; Liu Q; Hu C; Wang J; Su Y; Huang Y; Jiang H; Yu X
BMC Psychiatry; 2016 Jul; 16():240. PubMed ID: 27422150
[TBL] [Abstract][Full Text] [Related]
6. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
[TBL] [Abstract][Full Text] [Related]
7. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
8. Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder.
Wagner S; Helmreich I; Wollschläger D; Meyer K; Kaaden S; Reiff J; Roll SC; Braus D; Tüscher O; Müller-Dahlhaus F; Tadić A; Lieb K
PLoS One; 2018; 13(4):e0194574. PubMed ID: 29668746
[TBL] [Abstract][Full Text] [Related]
9. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
[TBL] [Abstract][Full Text] [Related]
10. Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression.
Williams LM; Debattista C; Duchemin AM; Schatzberg AF; Nemeroff CB
Transl Psychiatry; 2016 May; 6(5):e799. PubMed ID: 27138798
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal functional neuroimaging study in medication-naïve depression after antidepressant treatment.
Tomioka H; Yamagata B; Kawasaki S; Pu S; Iwanami A; Hirano J; Nakagome K; Mimura M
PLoS One; 2015; 10(3):e0120828. PubMed ID: 25786240
[TBL] [Abstract][Full Text] [Related]
12. Personalized medicine in major depressive disorder -- opportunities and pitfalls.
Miller DB; O'Callaghan JP
Metabolism; 2013 Jan; 62 Suppl 1(0 1):S34-9. PubMed ID: 23021040
[TBL] [Abstract][Full Text] [Related]
13. Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder.
Dreimüller N; Wagner S; Engel A; Braus DF; Roll SC; Elsner S; Tadić A; Lieb K
BMC Psychiatry; 2019 Jan; 19(1):24. PubMed ID: 30642308
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial.
Tadić A; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Röschke J; van Calker D; Wachtlin D; Kronfeld K; Gorbauch T; Seibert-Grafe M; Lieb K;
Trials; 2010 Feb; 11():21. PubMed ID: 20187947
[TBL] [Abstract][Full Text] [Related]
15. Impact of lingual gyrus volume on antidepressant response and neurocognitive functions in Major Depressive Disorder: a voxel-based morphometry study.
Jung J; Kang J; Won E; Nam K; Lee MS; Tae WS; Ham BJ
J Affect Disord; 2014 Dec; 169():179-87. PubMed ID: 25200096
[TBL] [Abstract][Full Text] [Related]
16. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
Kircanski K; Williams LM; Gotlib IH
Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
[TBL] [Abstract][Full Text] [Related]
17. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM
Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
[TBL] [Abstract][Full Text] [Related]
19. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
20. Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression.
Montano CB; Jackson WC; Vanacore D; Weisler R
Postgrad Med; 2023 Jun; 135(5):449-465. PubMed ID: 36912037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]